163. Deputy Rose Conway-Walsh asked the Minister for Health if a valproate stakeholder group will be established consisting of officials from his Department, the HSE, the HPRA, patient groups and other relevant stakeholders in order to provide greater oversight and co-ordination in ensuring measures introduced in 2018 to reduce the risks associated with valproate are being implemented effectively (details supplied); and if he will make a statement on the matter. [16255/20]

Summary

163. Deputy Rose Conway-Walsh asked the Minister for Health if a valproate stakeholder group will be established consisting of officials from his Department, the HSE, the HPRA, patient groups and other relevant stakeholders in order to provide greater oversight and co-ordination in ensuring measures introduced in 2018 to reduce the risks associated with valproate are being implemented effectively (details supplied); and if he will make a statement on the matter. [16255/20]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 15 July 2020

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.